Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion type Assertion NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_head.
- NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion description "[In gene-level analyses, CDC25C, SCC1/RAD21, TLK2, and SMC6L1 were associated (P�<�0.05) with overall breast cancer risk, CDC6, CDC27, SUMO3, RASSF1, KIF2, and CDC14A were associated with high grade breast cancer risk, and EIF3S10 and CDC25A were associated with both.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_provenance.
- NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion evidence source_evidence_literature NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_provenance.
- NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion SIO_000772 21607584 NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_provenance.
- NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion wasDerivedFrom befree-2016 NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_provenance.
- NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_assertion wasGeneratedBy ECO_0000203 NP896407.RAGNztuLKfD9LIuGijk6CmHbRxEO8edSeZJ786JEvUGe4130_provenance.